The issue of disclosure requirements with respect to sound prediction was addressed squarely by the Supreme Court in AstraZeneca Canada Inc. v. Apotex Inc., where the Court held that the so-called Promise Doctrine was not good law, in that it conflated the requirement for utility with the requirements for the specification.